🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.7400
-0.0200 (-2.63%)
At close: Nov 20, 2026

Pharmaniaga Berhad Income Statement

Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,1723,9283,7593,4043,4814,815
Revenue Growth
6.55%4.48%10.43%-2.20%-27.71%76.69%
Cost of Revenue
3,7463,5193,2193,0973,1384,185
Gross Profit
426.36409.16540.49307.82342.72630.02
Selling, General & Admin
272.84253.89251.96299.58292.6301.56
Amortization of Goodwill & Intangibles
4.094.094.075.645.173.61
Operating Expenses
298.46279.51279.57328.27314.72322.64
Operating Income
127.9129.65260.93-20.4528307.37
Interest Expense
-43.9-61.35-71.97-61.84-40.04-33.32
Interest & Investment Income
6.325.662.251.480.911.52
Currency Exchange Gain (Loss)
---1.130.040.93
Other Non Operating Income (Expenses)
-1.890.512.890.663.030.51
EBT Excluding Unusual Items
88.4274.47194.1-79.03-8.06277
Impairment of Goodwill
-----50.27-
Gain (Loss) on Sale of Assets
0.270.270.080.860.050.07
Asset Writedown
-----552.31-
Pretax Income
88.6974.74194.18-78.16-610.59277.08
Income Tax Expense
7.824.0560.390.5817.07104.87
Earnings From Continuing Operations
80.8850.68133.79-78.74-627.65172.21
Minority Interest in Earnings
-2.96-2.17-1.97-1.42-2.27-0.06
Net Income
77.9348.51131.82-80.16-629.92172.15
Net Income to Common
77.9348.51131.82-80.16-629.92172.15
Net Income Growth
80.54%-63.20%---526.25%
Shares Outstanding (Basic)
1,313723288274262262
Shares Outstanding (Diluted)
1,313723288274262262
Shares Change
182.17%150.74%5.38%4.40%0.05%0.04%
EPS (Basic)
0.060.070.46-0.29-2.400.66
EPS (Diluted)
0.060.070.46-0.29-2.400.66
EPS Growth
-36.11%-85.35%---526.09%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
19.22-47.4711.51-3.72-201.6-94.44
Free Cash Flow Per Share
0.01-0.070.04-0.01-0.77-0.36
Dividend Per Share
0.021---0.0950.465
Dividend Growth
-----79.57%322.73%
Gross Margin
10.22%10.42%14.38%9.04%9.85%13.08%
Operating Margin
3.06%3.30%6.94%-0.60%0.80%6.38%
Profit Margin
1.87%1.23%3.51%-2.35%-18.10%3.57%
Free Cash Flow Margin
0.46%-1.21%0.31%-0.11%-5.79%-1.96%
EBITDA
151.25154.29288.497.3555.62335.28
EBITDA Margin
3.62%3.93%7.67%0.22%1.60%6.96%
D&A For EBITDA
23.3524.6427.5727.7927.6227.9
EBIT
127.9129.65260.93-20.4528307.37
EBIT Margin
3.06%3.30%6.94%-0.60%0.80%6.38%
Effective Tax Rate
8.80%32.18%31.10%--37.85%